AGENDA

PDF Printer Friendly Version

7:30 a.m. – 8:25 a.m. Registration, Poster Setup, Light Refreshments
   
8:25 a.m. – 8:30 a.m.

Welcome
Sam Cushman, NIDDK

   
8:30 a.m. – 12:00 p.m.

Morning Session
Chair:  Jesse Roth, Albert Einstein College of Medicine, Yeshiva University

   
8:30 a.m. – 9:00 a.m.

Genomics and Pharmacogenetics in the Physiology and Treatment of Diabetes and Obesity
Marc Reitman, Merck & Co., Inc.

   
9:00 a.m. – 9:15 a.m.

Differential Regulation of Adipose Triglyceride Lipase (ATGL) and Hormone Sensitive Lipase (HSL) by Lipid Droplet-Associated Proteins (PAT Proteins)
Carole Sztalryd, University of Maryland School of Medicine

   
9:15 a.m. – 9:30 a.m.

Reduction of Adipose Tissue and Pancreatic Islet Inflammation by Sitagliptin in a Mouse Model of Obesity
Anca Dobrian, Eastern Virginia Medical School

   
9:30 a.m. – 9:45 a.m.

A Diabetic Fly Model:  Growth and Metabolic Defects Are Caused by Deletion of Drosophila Insulin-like Peptides
Caroline Li, University of Maryland

   
9:45 a.m. – 10:15 a.m. Break
   
10:15 a.m. – 10:45 a.m.

No, Bariatric Surgery Has Not Conquered Diabetes (Yet!):  Some Intriguing and Disturbing Puzzles
Walter Pories, East Carolina University

   
10:45 a.m. – 11:00 a.m.

Olanzapine Rapidly Stimulates Shifts in Peripheral Fuel Selection and Increases Whole-body Lipid Fuel Oxidation
Vance Albaugh, The Pennsylvania State University College of Medicine

   
11:00 a.m. – 11:15 a.m.

Beyond Thrombosis:  The Role of Plasminogen Activator Inhibitor Type-1 (PAI-1) in Obesity-induced Inflammation
Gina Coudriet, University of Pittsburgh School of Medicine

   
11:15 a.m. – 11:30 a.m.

Dynamics of Adipose Tissue Growth Under Weight Gain and Loss
Junghyo Jo, NIDDK

   
11:30 a.m. – 12:00 p.m.  

Metabolic Effects of Myostatin Inhibition
Alex McPherron, NIDDK

   
12:00 p.m. – 2:00 p.m. Lunch and Poster Session
   
2:00 p.m. – 4:30 p.m.

Afternoon Session
Chair:  Lester Salans, Mt. Sinai School of Medicine and Columbia University Medical Center

   
2:00 p.m. – 2:30 p.m.

Novel Pathways for Preserving Beta-cell Function in Type 2 Diabetes
Chris Newgard, Duke University Medical Center

   
2:30 p.m. – 2:45 p.m.

Caveolin-1 and Cholesterol Regulate GLP-1 Receptor Function in Pancreatic Islets
Stacey Barrick, University of Pittsburgh School of Medicine

   
2:45 p.m. – 3:00 p.m.

PERK (EIF2AK3) Regulates Proinsulin Trafficking and Quality Control in the Endoplasmic Reticulum
Douglas Cavener, The Pennsylvania State University

   
3:00 p.m. – 3:30 p.m. Break
   
3:30 p.m. – 3:45 p.m.

RGS4 and Spinophilin Are Negative Regulators M3 Muscarinic Acetylcholine Receptor-mediated Insulin Release
I. Ruiz de Azua, NIDDK

   
3:45 p.m. – 4:00 p.m.

O-GlcNAc Modification Is a Key Modulator for Insulin Production in Drosophila melanogaster
Osamu Sekine, NIDDK

   
4:00 p.m. – 4:30 p.m.

Dynamic Molecular Organization of GLUT4 and Insulin-stimulated Glucose Transport
Sam Cushman, NIDDK

   
4:30 p.m. – 4:35 p.m.

Wrap-up and Thanks
Sam Cushman, NIDDK

   
4:35 p.m. Adjournment, Poster Removal
   
 
NIDDK National Institutes of Health U.S. Department of Health & Human Services